​

GoodRx (GDRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

GoodRx Revenue Highlights

Latest Revenue (Y)

$792.32M

Latest Revenue (Q)

$196.03M

Main Segment (Y)

Prescription Transactions Revenue

GoodRx Revenue by Period

GoodRx Revenue by Year

DateRevenueChange
2024-12-31$792.32M5.61%
2023-12-31$750.26M-2.12%
2022-12-31$766.55M2.83%
2021-12-31$745.42M35.36%
2020-12-31$550.70M41.85%
2019-12-31$388.22M55.59%
2018-12-31$249.52M58.69%
2017-12-31$157.24M58.23%
2016-12-31$99.38M-

GoodRx generated $792.32M in revenue during NA 2024, up 5.61% compared to the previous quarter, and up 204.09% compared to the same period a year ago.

GoodRx Revenue by Quarter

DateRevenueChange
2025-09-30$196.03M-3.47%
2025-06-30$203.07M0.05%
2025-03-31$202.97M2.21%
2024-12-31$198.58M1.71%
2024-09-30$195.25M-2.67%
2024-06-30$200.61M1.38%
2024-03-31$197.88M0.63%
2023-12-31$196.64M9.27%
2023-09-30$179.96M-5.12%
2023-06-30$189.68M3.09%
2023-03-31$183.99M-0.07%
2022-12-31$184.11M-1.71%
2022-09-30$187.32M-2.34%
2022-06-30$191.80M-5.67%
2022-03-31$203.33M-4.65%
2021-12-31$213.26M9.30%
2021-09-30$195.10M10.45%
2021-06-30$176.63M10.10%
2021-03-31$160.43M4.49%
2020-12-31$153.54M9.32%
2020-09-30$140.45M13.92%
2020-06-30$123.30M-7.58%
2020-03-31$133.41M17.79%
2019-12-31$113.26M11.31%
2019-09-30$101.75M11.16%
2019-06-30$91.53M5.68%
2019-03-31$86.61M-

GoodRx generated $196.03M in revenue during Q3 2025, up -3.47% compared to the previous quarter, and up 97.72% compared to the same period a year ago.

GoodRx Revenue Breakdown

GoodRx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Prescription Transactions Revenue$577.55M$550.74M$550.54M$593.36M$488.26M
Subscription Revenue$86.54M$94.41M$96.17M$59.92M-
Other Revenue$21.00M$20.05M$20.43M$92.14M$62.44M

GoodRx's latest annual revenue breakdown by segment (product or service), as of Dec 24: Prescription Transactions Revenue (84.30%), Subscription Revenue (12.63%), and Other Revenue (3.07%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Subscription Revenue$20.72M$20.46M$21.02M$42.63M$21.31M$22.60M$23.15M$23.24M$23.88M$24.14M$24.62M$26.45M$25.98M$19.11M$17.38M$16.23M$14.32M---
Other Revenue$4.64M$4.56M$4.38M$10.24M$5.39M$5.38M$5.23M$5.39M$4.93M$4.50M$5.17M$5.15M$4.86M$5.24M$37.09M$23.22M$17.46M$26.37M$22.24M$16.07M
Prescription Transactions Revenue$127.29M$143.06M$148.92M$291.74M$140.42M$145.40M$143.86M$135.43M$136.54M$134.91M$129.41M$131.22M$134.40M$155.51M$158.79M$155.65M$144.86M$134.06M$131.31M$124.39M
Pharma Manufacturer Solutions Revenues--------$24.33M$20.43M$24.50M$26.55M$23.47M-------

GoodRx's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Prescription Transactions Revenue (83.39%), Subscription Revenue (13.58%), and Other Revenue (3.04%).

GoodRx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AHCOAdaptHealth$3.26B$820.31M
CTEVClaritev$930.62M$245.96M
GDRXGoodRx$792.32M$196.03M
AMPHAmphastar Pharmaceuticals$712.81M$191.84M
COLLCollegium Pharmaceutical$631.45M$209.36M
INVAInnoviva$358.71M$100.28M
MDXGMiMedx Group$348.88M$113.72M
HSTMHealthStream$291.65M$76.47M
LFMDLifeMD$158.44M$47.28M
IRMDIRadimed$73.24M$21.20M
PLSEPulse Biosciences--

GDRX Revenue FAQ

What is GoodRx’s yearly revenue?

GoodRx's yearly revenue for 2024 was $792.32M, representing an increase of 5.61% compared to 2023. The company's yearly revenue for 2023 was $750.26M, representing a decrease of -2.12% compared to 2022. GDRX's yearly revenue for 2022 was $766.55M, representing an increase of 2.83% compared to 2021.

What is GoodRx’s quarterly revenue?

GoodRx's quarterly revenue for Q3 2025 was $196.03M, a -3.47% decrease from the previous quarter (Q2 2025), and a 0.40% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $203.07M, a 0.05% increase from the previous quarter (Q1 2025), and a 1.23% increase year-over-year (Q2 2024). GDRX's quarterly revenue for Q1 2025 was $202.97M, a 2.21% increase from the previous quarter (Q4 2024), and a 2.57% increase year-over-year (Q1 2024).

What is GoodRx’s revenue growth rate?

GoodRx's revenue growth rate for the last 3 years (2022-2024) was 3.36%, and for the last 5 years (2020-2024) was 43.88%.

What are GoodRx’s revenue streams?

GoodRx's revenue streams in c 24 are Prescription Transactions Revenue, Subscription Revenue, and Other Revenue. Prescription Transactions Revenue generated $577.55M in revenue, accounting 84.30% of the company's total revenue, up 4.87% year-over-year. Subscription Revenue generated $86.54M in revenue, accounting 12.63% of the company's total revenue, down -8.34% year-over-year. Other Revenue generated $21M in revenue, accounting 3.07% of the company's total revenue, up 4.74% year-over-year.

What is GoodRx’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of GoodRx was Prescription Transactions Revenue. This segment made a revenue of $577.55M, representing 84.30% of the company's total revenue.